Services-Computer Processing & Data PreparationSIC 7374
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Clarivate PLC filings on SEC EDGAR ↗
Clarivate Plc completed the sale of its Life Sciences and Healthcare (LS&H) business to an affiliate of Altaris, LLC for an aggregate purchase price of $600 million. The consideration consists of $500 million in cash, a $75 million unsecured senior note, and $25 million in deferred cash consideration. The transaction represents a strategic shift for Clarivate and will be classified as discontinued operations.
Clarivate Plc completed the sale of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for total consideration of $600 million. The deal consists of $500 million in cash, a $75 million unsecured senior note, and $25 million in deferred cash consideration. The divestiture is intended to sharpen the company's focus on its Academia & Government and Intellectual Property segments while using proceeds to reduce debt.